LIFEPAK 35 ECG cable REF 11111-000041 Recall
LIFEPAK 35 ECG cable REF 11111-000041
FDA recall Class II
Ongoing
FDA lists this Class II recall for LIFEPAK 35 ECG cable REF 11111-000041. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1102-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jan 21, 2025
- FDA report date
- Feb 12, 2025
- Quantity in commerce
- 245 units
- Distribution
- See key details
- FDA cause
- Labeling Change Control
What is being recalled?
LIFEPAK 35 ECG cable REF 11111-000041
Affected model & UDI checker
Search the exact identifiers published for Z-1102-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 11111-000041 | LIFEPAK 35 ECG cable REF 11111-000041 | Check source notice | Not specified |
| Not specified | LIFEPAK 35 ECG cable REF 11111-000041 | Check source notice | 00883873834596 |
FDA code information
Catalog Number: 11111-000041 UDI-DI code: 00883873834596 Lot/Serial Number: 0224
Why was this product recalled?
Product shipped with incorrect IFU. IFU does not include proper cleaning/disinfection instructions
What actions did Physio-Control, Inc. take?
On 01/21/2025, the firm sent an "URGENT: MEDICAL DEVICE RECALL" Letter to customers informing them that Stryker discovered that an incorrect version of the Instructions for Use (IFU) for the 3-wire extended precordial ECG cable for the LIFEPAK 35 were distributed to customers. This version did not include information regarding disinfection of the 3-wire cable. Customer are instructed to: 1. Immediately check internal inventory to locate the product listed on the attached business reply form. 2. Remove and quarantine any affected product from use. 3. To confirm receipt of this Medical Device Correction Notice and understanding of the provided information, email the enclosed Business Reply Form (BRF) by January 31st, 2025 date, to [email protected]. 4. Upon receipt of the completed business reply form, Stryker will contact customers to arrange for the return and replacement of their product(s). 5. Maintain awareness of this communication internally until all required actions have been completed within their facility. Ensure this letter is kept with the affected device until replacement. 6. Inform Stryker if any of the subject devices have been distributed to other organizations by contacting Stryker at: a. Device Tracking: [email protected] b. Website: https://www.strykeremergencycare.com/service-support-overview/device-registration/ If you have any questions or concerns, contact Customer Service +1 800 442 1142 or by email [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1102-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology